SHERIDAN CAPITAL PARTNERS
SHERIDAN CAPITAL PARTNERS is a Series C+ and buyout fund in the US and Canada writing $30M–$150M checks into healthcare-tech, provider-services, outsourced-services, consumer-health, medical-products, employer-sponsored-benefits and alternative-health-plans.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech, provider-services, outsourced-services, consumer-health, medical-products, employer-sponsored-benefits, alternative-health-plans
- Check size
- $30M–$150M
- Invests in
- US-wide, Canada
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 2012
- Assets under management
- $1.48B
- Website
- sheridancp.com
Thesis
Sheridan Capital Partners is a private equity firm founded in 2012 and headquartered in Chicago, Illinois, with a dedicated focus on the healthcare sector. They exclusively invest in lower middle-market healthcare businesses in the United States and Canada, employing a control-oriented strategy that includes buyouts and growth equity. Their investment thesis centers on partnering with founder-owned, entrepreneurially-led companies that exhibit strong business models, consistent growth and profitability, and operate within fragmented markets with positive secular growth trends. Sheridan avoids businesses with significant regulatory risk and looks for strong demand and revenue visibility. Their approach is collaborative and hands-on, leveraging capital markets sophistication and operational resources to drive value creation through improvements in people, process, and systems. They facilitate growth via organic initiatives and M&A, offering capital, strategy, and integration support for accretive acquisitions. Key investment verticals include providers and provider services, healthcare IT and outsourced services, and consumer health and medical products, with a specific interest in employer-sponsored benefits and alternative health plans. As of December 31, 2025, their total AUM was over $1.48 billion, managed across funds like Sheridan Capital Partners Fund II ($306M) and Fund III ($575M). They target platform companies with $3M-$20M in EBITDA and equity investments ranging from $30M-$150M, also engaging in add-on investments.
Common questions
Does SHERIDAN CAPITAL PARTNERS invest at the Series C+ stage?
Yes. SHERIDAN CAPITAL PARTNERS lists Series C+ and buyout among the stages it invests in.
What check size does SHERIDAN CAPITAL PARTNERS write?
SHERIDAN CAPITAL PARTNERS writes $30M–$150M checks.
Where does SHERIDAN CAPITAL PARTNERS invest?
SHERIDAN CAPITAL PARTNERS invests in the US and Canada.